Lung metastases in oligometastatic patients: outcome with stereotactic body radiation therapy (SBRT)

[11] Philip A(2010)Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee Radiat Oncol Biol 78 3-4101

[12] Milano MT(2010)Stereotactic body radiation therapy: the report of AAPM Task Group 101 Med Phys 37 4078-532

[13] Katz AW(2010)Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer J Thorac Oncol 5 526-471

[14] Boros L(2014)Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival Ann Oncol 25 467-118

[15] Rusthoven KE(2009)Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 73 112-442

[16] Kavanagh BD(2007)Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study Radiother Oncol 85 435-282

[17] Burri SH(2012)The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study Radiat Oncol 7 216-undefined

[18] Chen C(2013)Radiotherapy and oncology Radiother Oncol 106 276-undefined

[19] Cardenes H(2012)oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific micrornas. Sarkar in, ed PLoS One 7 e50141-undefined

[20] Chidel MA(undefined)undefined undefined undefined undefined-undefined

[11] Philip A(2010)Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee Radiat Oncol Biol 78 3-4101

[12] Milano MT(2010)Stereotactic body radiation therapy: the report of AAPM Task Group 101 Med Phys 37 4078-532

[13] Katz AW(2010)Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer J Thorac Oncol 5 526-471

[14] Boros L(2014)Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival Ann Oncol 25 467-118

[15] Rusthoven KE(2009)Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 73 112-442

[16] Kavanagh BD(2007)Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study Radiother Oncol 85 435-282

[17] Burri SH(2012)The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study Radiat Oncol 7 216-undefined

[18] Chen C(2013)Radiotherapy and oncology Radiother Oncol 106 276-undefined

[19] Cardenes H(2012)oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific micrornas. Sarkar in, ed PLoS One 7 e50141-undefined

[20] Chidel MA(undefined)undefined undefined undefined undefined-undefined